Lexeo Therapeutics, Inc. (LXEO)
Nasdaq: LXEO · CIK 0001907108 · United States
Every official Lexeo Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open LXEO filings
Lexeo Therapeutics, Inc. documents
- Lexeo Therapeutics, Inc. 10-K 2026LXEO 10-K 2026: annual report for fiscal 2026
- Lexeo Therapeutics, Inc. 10-K 2025LXEO 10-K 2025: annual report for fiscal 2025
- Lexeo Therapeutics, Inc. 10-K 2024LXEO 10-K 2024: annual report for fiscal 2024
- Lexeo Therapeutics, Inc. 10-K 2023LXEO 10-K 2023: annual report for fiscal 2023
- Lexeo Therapeutics, Inc. 10-K 2022LXEO 10-K 2022: annual report for fiscal 2022
- Lexeo Therapeutics, Inc. 10-Q 2026LXEO 10-Q 2026: quarterly report for fiscal 2026
- Lexeo Therapeutics, Inc. 10-Q 2025LXEO 10-Q 2025: quarterly report for fiscal 2025
- Lexeo Therapeutics, Inc. 10-Q 2024LXEO 10-Q 2024: quarterly report for fiscal 2024
- Lexeo Therapeutics, Inc. 10-Q 2023LXEO 10-Q 2023: quarterly report for fiscal 2023
- Lexeo Therapeutics, Inc. 10-Q 2022LXEO 10-Q 2022: quarterly report for fiscal 2022
- Lexeo Therapeutics, Inc. 8-K 2026LXEO 8-K 2026: current report for fiscal 2026
- Lexeo Therapeutics, Inc. 8-K 2025LXEO 8-K 2025: current report for fiscal 2025
- Lexeo Therapeutics, Inc. 8-K 2024LXEO 8-K 2024: current report for fiscal 2024
- Lexeo Therapeutics, Inc. 8-K 2023LXEO 8-K 2023: current report for fiscal 2023
- Lexeo Therapeutics, Inc. 8-K 2022LXEO 8-K 2022: current report for fiscal 2022
- Lexeo Therapeutics, Inc. DEF 14A 2026LXEO DEF 14A 2026: proxy statement for fiscal 2026
- Lexeo Therapeutics, Inc. DEF 14A 2025LXEO DEF 14A 2025: proxy statement for fiscal 2025
- Lexeo Therapeutics, Inc. DEF 14A 2024LXEO DEF 14A 2024: proxy statement for fiscal 2024
- Lexeo Therapeutics, Inc. DEF 14A 2023LXEO DEF 14A 2023: proxy statement for fiscal 2023
- Lexeo Therapeutics, Inc. DEF 14A 2022LXEO DEF 14A 2022: proxy statement for fiscal 2022
- Lexeo Therapeutics, Inc. Form 4 2026LXEO Form 4 2026: insider trading filing for fiscal 2026
- Lexeo Therapeutics, Inc. Form 4 2025LXEO Form 4 2025: insider trading filing for fiscal 2025
- Lexeo Therapeutics, Inc. Form 4 2024LXEO Form 4 2024: insider trading filing for fiscal 2024
- Lexeo Therapeutics, Inc. Form 4 2023LXEO Form 4 2023: insider trading filing for fiscal 2023
- Lexeo Therapeutics, Inc. Form 4 2022LXEO Form 4 2022: insider trading filing for fiscal 2022
- Lexeo Therapeutics, Inc. S-1 2026LXEO S-1 2026: registration statement for fiscal 2026
- Lexeo Therapeutics, Inc. S-1 2025LXEO S-1 2025: registration statement for fiscal 2025
- Lexeo Therapeutics, Inc. S-1 2024LXEO S-1 2024: registration statement for fiscal 2024
- Lexeo Therapeutics, Inc. S-1 2023LXEO S-1 2023: registration statement for fiscal 2023
- Lexeo Therapeutics, Inc. S-1 2022LXEO S-1 2022: registration statement for fiscal 2022
- Lexeo Therapeutics, Inc. 13F 2026LXEO 13F 2026: institutional holdings for fiscal 2026
- Lexeo Therapeutics, Inc. 13F 2025LXEO 13F 2025: institutional holdings for fiscal 2025
- Lexeo Therapeutics, Inc. 13F 2024LXEO 13F 2024: institutional holdings for fiscal 2024
- Lexeo Therapeutics, Inc. 13F 2023LXEO 13F 2023: institutional holdings for fiscal 2023
- Lexeo Therapeutics, Inc. 13F 2022LXEO 13F 2022: institutional holdings for fiscal 2022
More companies